Genetics of long-QT syndrome

[1]  T. Meitinger,et al.  Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2 , 2015, Circulation. Cardiovascular genetics.

[2]  A. Wilde,et al.  Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. , 2015, European heart journal.

[3]  R. Myerburg.  Physiological variations, environmental factors, and genetic modifications in inherited LQT syndromes. , 2015, Journal of the American College of Cardiology.

[4]  Alberto Porta,et al.  Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1. , 2015, Journal of the American College of Cardiology.

[5]  J. Brugada,et al.  Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology , 2014, PloS one.

[6]  Milena Bellin,et al.  Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue , 2014, Proceedings of the National Academy of Sciences.

[7]  M. Horie,et al.  Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  Wenjian Jiang,et al.  Human Induced Pluripotent Stem Cell Models of Inherited Cardiovascular Diseases. , 2014 .

[9]  Euan A Ashley,et al.  Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing. , 2014, Heart rhythm.

[10]  Takeshi Tsuchiya,et al.  Novel Calmodulin Mutations Associated With Congenital Arrhythmia Susceptibility , 2014, Circulation. Cardiovascular genetics.

[11]  V. Cameron,et al.  Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. , 2014, Heart rhythm.

[12]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[13]  Michael J. Ackerman,et al.  Exome Sequencing and Systems Biology Converge to Identify Novel Mutations in the L-Type Calcium Channel, CACNA1C, Linked to Autosomal Dominant Long QT Syndrome , 2013, Circulation. Cardiovascular genetics.

[14]  Thomas Meitinger,et al.  Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.

[15]  Gordon Keller,et al.  Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics , 2013, The Journal of general physiology.

[16]  K. Hayashi,et al.  A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome. , 2013, Heart rhythm.

[17]  E. Kaufman,et al.  Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to &bgr;-Blocker Therapy in Type 1 Long-QT Syndrome , 2012, Circulation.

[18]  Edward P Cheng,et al.  L-type Ca2+ channel function during Timothy syndrome. , 2012, Trends in cardiovascular medicine.

[19]  W. Shou,et al.  Cardiac Sodium Channel Nav1.5 Mutations and Cardiac Arrhythmia , 2012, Pediatric Cardiology.

[20]  G. Sadjadieh,et al.  High prevalence of genetic variants previously associated with LQT syndrome in new exome data , 2012, European Journal of Human Genetics.

[21]  P. Schwartz,et al.  QTc behavior during exercise and genetic testing for the long-QT syndrome. , 2011, Circulation.

[22]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  H. Calkins,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.

[24]  R. Brugada,et al.  Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Voltage – Dependent L-Type Calcium Channel , 2011 .

[25]  Amy Maxmen,et al.  Exome Sequencing Deciphers Rare Diseases , 2011, Cell.

[26]  Andrew J. Wilson,et al.  Mechanisms of disease pathogenesis in long QT syndrome type 5. , 2010, American journal of physiology. Cell physiology.

[27]  L. Biesecker.  Exome sequencing makes medical genomics a reality , 2010, Nature Genetics.

[28]  Michael J Ackerman,et al.  Genotype-phenotype aspects of type 2 long QT syndrome. , 2009, Journal of the American College of Cardiology.

[29]  Fabio Mosca,et al.  Prevalence of the Congenital Long-QT Syndrome , 2009, Circulation.

[30]  Thomas Lumley,et al.  Common variants at ten loci influence QT interval duration in the QTGEN Study , 2009, Nature Genetics.

[31]  Christian Gieger,et al.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study , 2009, Nature Genetics.

[32]  W. Shimizu.  Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[33]  E. Behr,et al.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. , 2008, The Journal of clinical investigation.

[34]  E. Behr,et al.  The E 1784 K mutation in SCN 5 A is associated with mixed clinical phenotype of type 3 long QT syndrome , 2008 .

[35]  Michael J. Ackerman,et al.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome , 2007, Proceedings of the National Academy of Sciences.

[36]  Michael J Ackerman,et al.  SCN4B-Encoded Sodium Channel &bgr;4 Subunit in Congenital Long-QT Syndrome , 2007, Circulation.

[37]  Bba,et al.  Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene , 2007, Circulation.

[38]  Lauri Toivonen,et al.  The Jervell and Lange-Nielsen Syndrome: Natural History, Molecular Basis, and Clinical Outcome , 2006, Archives des maladies du coeur et des vaisseaux.

[39]  J. Stockman.  Genetic Testing in the Long QT Syndrome: Development and Validation of an Efficient Approach to Genotyping in Clinical Practice , 2007 .

[40]  Michael J Ackerman,et al.  Mutant Caveolin-3 Induces Persistent Late Sodium Current and Is Associated With Long-QT Syndrome , 2006, Circulation.

[41]  Patrick Ruchat,et al.  Cardiac Sodium Channel Nav1.5 Is Regulated by a Multiprotein Complex Composed of Syntrophins and Dystrophin , 2006, Circulation research.

[42]  D. Tester,et al.  Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. , 2006, Heart rhythm.

[43]  C. January,et al.  HERG trafficking and pharmacological rescue of LQTS-2 mutant channels. , 2006, Handbook of experimental pharmacology.

[44]  S. Priori,et al.  Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. , 2005, JAMA.

[45]  A. Wilde,et al.  A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. , 2005, Journal of molecular and cellular cardiology.

[46]  S. Priori,et al.  Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. , 2004, Journal of the American College of Cardiology.

[47]  J. Vandenberg,et al.  Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro‐arrhythmia in long QT syndrome type 6 , 2003, The Journal of physiology.

[48]  Hubert Kwiecinski,et al.  Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). , 2002, The Journal of clinical investigation.

[49]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[50]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[51]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[52]  F. Conti,et al.  Structural parts involved in activation and inactivation of the sodium channel , 1989, Nature.